Virtus Investment Advisers’s Gilead Sciences GILD Stock Holding History

Virtus Investment Advisers’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.85M	Buy	20,473 +14,798	+261%	+$2.07M	0.79%	1
2025 Q4	$697K	Buy	5,675 +1,709	+43%	+$208K	0.19%	166
2025 Q3	$440K	Hold	3,966	–	–	0.13%	215
2025 Q2	$440K	Buy	3,966 +46	+1%	+$4.9K	0.15%	206
2025 Q1	$439K	Buy	+3,920	New	+$404K	0.12%	204
2023 Q3	–	Sell	-2,881	Closed	-$222K	–	261
2023 Q2	$222K	Sell	2,881 -2,895	-50%	-$231K	0.15%	178
2023 Q1	$479K	Hold	5,776	–	–	0.34%	95
2022 Q4	$496K	Hold	5,776	–	–	0.33%	89
2022 Q3	$356K	Buy	+5,776	New	+$364K	0.16%	126
2018 Q1	–	Sell	-5,558	Closed	-$398K	–	179
2017 Q4	$398K	Buy	5,558 +282	+5%	+$21.4K	0.04%	323
2017 Q3	$427K	Sell	5,276 -1,127	-18%	-$86.2K	0.04%	337
2017 Q2	$453K	Sell	6,403 -1,230	-16%	-$81.8K	0.04%	334
2017 Q1	$518K	Buy	+7,633	New	+$537K	0.05%	322
2016 Q4	–	Sell	-28,122	Closed	-$2.23M	–	496
2016 Q3	$2.23M	Buy	+28,122	New	+$2.28M	0.14%	208

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Virtus Investment Advisers's GILD Position: Q1 2026 in Review

Virtus Investment Advisers increased its Gilead Sciences (GILD) stake by 261% in Q1 2026, buying an estimated $2.07M and bringing the position to 20,473 shares worth $2.85M. The position accounts for 0.79% of the portfolio, ranked #1.

Virtus Investment Advisers first reported a position in GILD in Q3 2016 and has held it in 14 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Virtus Investment Advisers held 20,473 shares of Gilead Sciences worth $2.85M as of Q1 2026.
Virtus Investment Advisers bought 14,798 Gilead Sciences shares in Q1 2026, an estimated $2.07M.
Gilead Sciences made up 0.79% of Virtus Investment Advisers's portfolio in Q1 2026, its #1 holding.
Virtus Investment Advisers first reported a position in Gilead Sciences in Q3 2016 and has held it in 14 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.